spacer
CDC Home > HIV/AIDSTopics > Statistics and Surveillance > Reports > Demographic and Behavioral Data from a Supplemental HIV/AIDS Behavioral Surveillance Project 1997–2000
spacer
Demographic and Behavioral Data from a Supplemental HIV/AIDS Behavioral Surveillance Project 1997–2000
space
arrow Cover
space
arrow Commentary
space
arrow Figure 1
space
arrow Table 1a
space
arrow Table 1b
space
arrow Table 2
space
arrow Table 3
space
arrow Table 4
space
arrow Table 5
space
arrow Figure 2
space
arrow Table 6
space
arrow Figure 3
space
arrow Table 7
space
arrow Table 8
space
arrow Table 9
space
arrow Table 10
space
arrow Figure 4
space
arrow Figure 5
space
arrow Table 11
space
arrow Table 12
space
arrow Table 13
space
arrow Table 14
space
arrow Table 15
space
arrow Table 16
space
arrow Technical Notes
space
 
LEGEND:
PDF Icon   Link to a PDF document
Non-CDC Web Link   Link to non-governmental site and does not necessarily represent the views of the CDC
Adobe Acrobat (TM) Reader needs to be installed on your computer in order to read documents in PDF format. Download the Reader.
spacer spacer
spacer
Skip Nav spacer
Technical Notes
spacer
spacer

The Supplement to HIV/AIDS Surveillance (SHAS), a cross-sectional interview project begun in 1990, is designed to collect behavioral surveillance data beyond what is found on the standard HIV/AIDS case report form. The study has been reviewed and approved by institutional review boards (IRBs) at the CDC and local levels. HIV-infected persons who are age 18 years and older, who are reported through routine disease surveillance to participating state and local health departments, and who, at some sites, attend a participating health care facility, are eligible for interview. During the period covered by this report, 12 health departments participated in SHAS. Participants are enrolled through 1 of 3 methods: (a) facility-based recruitment of all eligible persons seeking treatment at selected health care facilities in Denver (Colorado), Hartford and New Haven (Connecticut), Jacksonville, Miami and Tampa (Florida), Atlanta (Georgia), Detroit (Michigan), and Jersey City and Paterson (New Jersey); (b) population-based recruitment of all eligible persons in Arizona, Delaware, New Mexico and South Carolina (3 health districts); and (c) population-based recruitment of a 30% sample of men who have sex with men (MSM) and 100% of all other eligible persons in the state of Washington and Los Angeles County, California. At 7 sites (Arizona, Denver, Detroit, Florida, New Jersey, New Mexico and South Carolina) persons with HIV and AIDS were interviewed; at the remaining sites only persons with AIDS were interviewed. (Florida began reporting cases of HIV infection [not AIDS] in July 1997 and New Mexico instituted their HIV reporting in January 1998.) After obtaining informed consent, trained interviewers administer a standard questionnaire in either English or Spanish. The data collection modules include questions about demographics, drug and alcohol use, sexual behaviors, HIV diagnosis and treatment, and use of social services.

Over time the project questionnaire has been modified to collect data on emerging issues related to the HIV epidemic. Data in this report are from SHAS interviews conducted from June 1997 through December 2000. Highly active antiretroviral therapies (HAART) became widely available in the mid-1990s, and soon after, questions on the use of, and adherence to, these therapies were added to the SHAS questionnaire.

Table 2 shows the demographic characteristics of SHAS participants. By use of a recoding algorithm, persons are assigned into the Hispanic race/ethnicity category if they considered themselves to be Hispanic or Latino, regardless of the racial category they designated. Behavioral data from SHAS are used to refine the HIV exposure risk recorded in the national HIV/AIDS Reporting System (HARS). In HARS, the category of exposure to HIV is determined primarily through review of medical records. For surveillance purposes, HIV infection cases and AIDS cases are counted only once in a hierarchy of exposure categories. Persons with more than one reported mode of exposure to HIV infection are classified in the exposure category listed first in the hierarchy (except for men with a history of both male-to-male sexual contact and injection drug use; they are assigned to a separate exposure category). Risk behavior reported in SHAS (for example, injection drug use, male-to-male sexual contact, or heterosexual contact with an HIV-infected person) is used to reclassify a person without a designated risk in HARS into the appropriate risk category in the hierarchy. Behavioral data from SHAS were used to reclassify risk for 154 persons.

Tables 3, 4 and 5 report data on sexual risk behaviors among 3 racial/ethnic groups: non-Hispanic white, non-Hispanic black, and Hispanic, by type of sex partner during the 12 months before the SHAS interview. The group reported as “Men with male sex partners” comprises men who had sex exclusively with men as well as those who had sex with both men and women. The group reported as “Men with female sex partners” comprises men who reported sex exclusively with women; the group reported as “Women with male sex partners” comprises women who reported sex exclusively with men as well as those who had sex with both men and women. In Tables 3, 4, 5, “inconsistent condom use” is defined as using condoms less than half the time (includes “sometimes” and “never”).

Figure 3 displays proportions of persons who reported having ever being treated for a sexually transmitted disease (STD), by race/ethnicity and type of sex partner. The array of STDs making up the question include: gonorrhea (genital, oral or rectal), syphilis, trichomoniasis, Chlamydia, anal/genital warts, anal/genital herpes, genital ulcers, pelvic inflammatory disease (for women only), and “other” STD.

Tables 7 and 8 show data on drug- and alcohol-use behavior by participants’ race/ethnicity and age, respectively. “Possible alcohol abuse” is defined as 2 or more positive responses to the CAGE standardized questions, which are used to screen for possible alcohol abuse (1): “Have you ever felt you should Cut down on your drinking?”; “Have people Annoyed you by criticizing your drinking?”; “Have you ever felt Guilty about your drinking?”; “Have you ever had a drink first thing in the morning to steady your nerves or get rid of a hang-over (Eyeopener)?”.

References

  1. Bush B, Shaw S, Cleary P, Delbanco TL, Aronson MD. Screening for alcohol abuse using the CAGE questionnaire. Am J Med, 1987;82:231-235.
spacer
Last Modified: August 9, 2006
Last Reviewed: August 9, 2006
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
spacer
spacer
spacer
Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
spacer USA.gov: The U.S. Government's Official Web PortalDHHS Department of Health
and Human Services